Prospective in-silico trials identify combined SK and K2P channel block as an effective strategy for atrial fibrillation cardioversion - Supplement (Q6702023)

The dataset contains a Supplemental Material for the paper "Prospective in-silico trials identify combined SK and K2P channel block as an effective strategy for atrial fibrillation cardioversion",DOI: 10.1113/JP287124 Moreover, it includes 10 simulations conducted in a representative cohort of 10 non-cardioverted virtual patients that originally presented sustained AF for 5 seconds after drug simulation. The new simulations were run for 5 additional seconds, for a total duration of 10 seconds of simulated pharmacological action. The two drug treatments resulting in lower cardioversion efficacy (i.e., single SK and K2P channel block) were considered.